Elkfork Partners’s Boston Scientific BSX Stock Holding History

Elkfork Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.03M	Sell	74,382 -21,384	-22%	-$906K	0.07%	216
2019 Q2	$4.12M	Buy	95,766 +47,850	+100%	+$1.84M	0.1%	183
2019 Q1	$1.84M	Buy	47,916 +2,618	+6%	+$100K	0.05%	276
2018 Q4	$1.6M	Buy	45,298 +13,310	+42%	+$483K	0.05%	278
2018 Q3	$1.23M	Sell	31,988 -2,332	-7%	-$81.4K	0.03%	336
2018 Q2	$1.12M	Buy	34,320 +1,364	+4%	+$41.1K	0.03%	328
2018 Q1	$901K	Sell	32,956 -8,426	-20%	-$229K	0.02%	359
2017 Q4	$1.03M	Sell	41,382 -7,194	-15%	-$198K	0.03%	358
2017 Q3	$1.42M	Sell	48,576 -99,022	-67%	-$2.73M	0.04%	283
2017 Q2	$4.09M	Sell	147,598 -80,718	-35%	-$2.14M	0.12%	151
2017 Q1	$5.68M	Sell	228,316 -33,000	-13%	-$802K	0.17%	115
2016 Q4	$5.65M	Buy	+261,316	New	+$5.7M	0.19%	104

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Elkfork Partners's BSX Position: Q3 2019 in Review

Elkfork Partners reduced its Boston Scientific (BSX) stake by 22% in Q3 2019, selling an estimated $906K and leaving 74,382 shares worth $3.03M. The position accounts for 0.07% of the portfolio, ranked #216.

Elkfork Partners first reported a position in BSX in Q4 2016 and has held it in 12 quarters since. The position peaked at $5.68M in Q1 2017. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

Elkfork Partners held 74,382 shares of Boston Scientific worth $3.03M as of Q3 2019.
Elkfork Partners sold 21,384 Boston Scientific shares in Q3 2019, an estimated $906K.
Boston Scientific made up 0.07% of Elkfork Partners's portfolio in Q3 2019, its #216 holding.
Elkfork Partners first reported a position in Boston Scientific in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Boston Scientific position peaked at $5.68M in Q1 2017.
771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.